Australia markets open in 7 hours 38 minutes
Explore/

Biggest Earnings Beats

Biggest Earnings Beats

9.34k followers15 symbols Watchlist by Yahoo Finance

This list tracks the largest earnings beats for companies recently reporting earnings. This list is produced daily using the real-time earnings results reported by Selerity and limited to the top 30 stocks that meet the criteria.

Curated by Yahoo Finance

This list tracks the largest earnings beats for companies recently reporting earnings. This list is produced daily using the real-time earnings results reported by Selerity and limited to the top 30 stocks that meet the criteria.

Background

Yahoo Finance employs sophisticated algorithms to monitor and detect trends in the Global Financial Markets. We bring these insights to you in the form of watchlists.

Find other winning investment ideas with the Yahoo Finance Screener.

How are these weighted?

The stocks in this watchlist are weighted equally.

Performance

WatchlistChange today1-month return1-year returnTotal return
Biggest Earnings Beats+2.88%---
^GSPC-0.46%-0.21%+40.64%+4367.20%

15 symbols

SymbolCompany nameLast priceChange% changeMarket timeVolumeAvg vol (3-month)Market cap
DISThe Walt Disney Company169.79-3.91-2.25%12:22 pm GMT-48.73M10.70M308.21B
IFFInternational Flavors & Fragrances Inc.142.12+0.91+0.64%12:21 pm GMT-4329.76k1.91M35.38B
OXYOccidental Petroleum Corporation25.675+0.57+2.29%12:22 pm GMT-47.39M19.02M23.97B
UUnity Software Inc.84.9825-2.50-2.85%12:22 pm GMT-41.30M4.26M23.75B
NLOKNortonLifeLock Inc.26.085-0.01-0.02%12:21 pm GMT-44.00M5.47M15.18B
NUANNuance Communications, Inc.52.535-0.03-0.05%12:21 pm GMT-41.61M8.11M15.03B
TREXTrex Company, Inc.100.87-3.82-3.65%12:21 pm GMT-4207.13k753.75k11.64B
NVAXNovavax, Inc.133.05+1.36+1.03%12:21 pm GMT-41.45M3.71M9.86B
BRKSBrooks Automation, Inc.88.935-3.18-3.45%12:21 pm GMT-4321.27k787.17k6.61B
COHRCoherent, Inc.259.47+1.00+0.39%12:17 pm GMT-452.37k426.54k6.37B
JCOMJ2 Global, Inc.125.65+0.44+0.35%12:20 pm GMT-4135.47k627.11k5.67B
GOOSCanada Goose Holdings Inc.38.04-0.16-0.42%12:21 pm GMT-4491.65k1.02M4.18B
NARIInari Medical, Inc.80.7944-0.15-0.18%12:21 pm GMT-4304.40k622.10k4.01B
DDD3D Systems Corporation22.85+0.52+2.33%12:22 pm GMT-44.81M5.34M2.86B
  • AT&T Will Spin Off HBO to Merge With Discovery
    Motley Fool

    AT&T Will Spin Off HBO to Merge With Discovery

    The streaming landscape just got a little more interesting. In a joint press release on Monday, AT&T (NYSE: T) and Discovery (NASDAQ: DISCA) (NASDAQ: DISCK) announced that WarnerMedia would be spun off and merged with Discovery to create a new stand-alone company.

  • DEADLINE ALERT for DDD, DOX, SHRMF, and FGEN: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
    GlobeNewswire

    DEADLINE ALERT for DDD, DOX, SHRMF, and FGEN: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

    LOS ANGELES, May 17, 2021 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to fcruz@frankcruzlaw.com. 3D Systems Corporation (NYSE: DDD)Class Period: May 6, 2020 – March 1, 2021Lead Plaintiff Deadline: June 8, 2021 The complaint filed alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) 3D Systems lacked proper internal controls over financial reporting; and (2) as a result, Defendants' statements about its business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. Amdocs Limited (NASDAQ: DOX)Class Period: December 13, 2016 – March 30, 2021Lead Plaintiff Deadline: June 8, 2021 The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) Amdocs overstated its profits, cash, and liquidity, while understating its debt; (2) Amdocs concealed its large borrowing; (3) while Amdocs' reported results showed that its North American business was stable, that business was actually deteriorating annually, in part because the Company was losing AT&T as a customer; and (4) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times. Champignon Brands Inc. (OTC: SHRMF)Class Period: March 27, 2020 – February 17, 2021Lead Plaintiff Deadline: June 9, 2021 The complaint filed alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) Champignon had undisclosed material weaknesses and insufficient financial controls; (2) Champignon's previously issued financial statements were false and unreliable; (3) Champignon's earlier reported financial statements would need to be restated; (4) Champignon's acquisitions involved an undisclosed related party; (5) as a result of the foregoing and subsequent reporting delays and issues, the British Columbia Securities Commission would suspend Champignon's stock from trading; (6) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. FibroGen Inc. (NASDAQ: FGEN)Class Period: October 18, 2017 – April 6, 2021Lead Plaintiff Deadline: June 11, 2021 Shareholders with $100,000 losses or more are encouraged to contact the firm The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that certain safety analyses submitted in connection with FibroGen’s NDA for roxadustat included post-hoc changes to stratification factors; (2) that, based on analyses using the pre-specified stratification factors, the Company could not conclude that roxadustat reduces the risk of major adverse cardiovascular events compared to epoetin-alfa; (3) that, as a result, the Company faced significant uncertainty that its NDA for roxadustat as a treatment for anemia of CKD would be approved by the FDA; and (4) as a result, Defendants’ statements about its business, operations, and prospects were materially false and misleading and/or lacked reasonable basis at all relevant times. Follow us for updates on Twitter: twitter.com/FRC_LAW. To be a member of these class actions, you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about these class actions, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. Contacts The Law Offices of Frank R. Cruz, Los AngelesFrank R. Cruz, 310-914-5007fcruz@frankcruzlaw.comwww.frankcruzlaw.com

  • Is Disney Stock Still a Buy After Missing Subscriber Estimates?
    Motley Fool

    Is Disney Stock Still a Buy After Missing Subscriber Estimates?

    Walt Disney (NYSE: DIS) ended the fiscal second quarter with 103.6 million subscribers on its Disney+ streaming service. While that's more than double the total reported in the year-ago quarter, analysts expected Disney+ to finish the quarter with 109 million subscribers. Here are four important points from the earnings call that suggest Disney is doing fine and could make the sell-off a good buying opportunity.